F-Prime Capital Partners vs OrbiMed
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| F-Prime Capital Partners | OrbiMed | |
|---|---|---|
| Type | Venture capital | Venture capital |
| HQ | Cambridge | New York |
| Founded | 2002 | 1999 |
| Check size | $3M – $10M | $1M – $75M |
| Stages | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage | Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Crypto & Web3, Deep Tech, Digital Health, Enterprise Software, Fintech, Healthtech, Medical Devices, SaaS | Biotech, Digital Health, Healthtech, Longevity, Medical Devices |
| AUM | $13B | $20.6B |
| Tracked investments | 378 | 205 |
| Exits (acquired/public) | 6 | — |
| Dated deals, last 24 mo | 5 | 5 |
Shared portfolio · 8
AdelabioCarrot FertilityCharmtxCompass TherapeuticsInsilico MedicineInsmedOncusp TherapeuticsTandemai
Frequently asked questions
- Do F-Prime Capital Partners and OrbiMed invest together?
- Yes — F-Prime Capital Partners and OrbiMed appear together in 8 tracked portfolio companies, including Adelabio, Carrot Fertility, Charmtx, Compass Therapeutics, Insilico Medicine.
- How do F-Prime Capital Partners and OrbiMed compare on check size?
- F-Prime Capital Partners typically writes checks of $3M – $10M, while OrbiMed writes $1M – $75M.